Arab Pharmaceuticals (ADCI) trades on the Egyptian Exchange (EGX) in the Health Care & Pharmaceuticals sector. Last updated 28 Oct 2026, 13:50 (Cairo time).
What is Arab Pharmaceuticals’s share price today? ADCI last traded at EGP 260.07 (+1.26% on the day), for a market value of EGP 2.83 billion, a P/E of 13.26 and a dividend yield of 3.20%. Its 52-week range is EGP 140 to 389.99.
Price change from EGX closing prices, adjusted for recorded splits and bonus issues; cash dividends are not included. A period that spans an unexplained price jump is not shown. Past performance does not indicate future results.
Arab Pharmaceuticals engages in the manufacture, packaging, distribution and trade of drugs, pharmaceuticals, and chemicals. Its products include ampoules, tablets, syrups, solutions, capsules, aerosol sprays, metered dose inhalers, granulated powder for suspension, creams, ointments, and suppositories. The company is also involved in the purchase and sale of compounds, raw materials, and related products. Arab Pharmaceuticals was founded on November 7, 1964 and is headquartered in Cairo, Egypt.
Data as of 28 Oct 2026, 13:50 (Cairo time). EGX market data; financial statements from company disclosures. Prices are delayed 15 minutes during EGX trading hours (Sun–Thu).